Cell therapy has been gaining more and more attention in medical procedures providing acceptable results and thereby efficiently satisfying the mission entrusted by specialists in hematology. The moral principles, together with the professional ethical conduct, demand new positions. The evolution of biotechnology and biotechnoscience carries a considerable amount of human knowledge, but requires the development and refinement of ethical concepts, bringing together social approval and bioethics. More than ever the doctor is geared to conduct an analysis and take into consideration the patient or his guardian. The purpose of this present study is to discuss the main roots of ethics, since its birth, its transformation in philosophical thought, its suitability in the professional field, the materialization of the Code of Medical Ethics and the severance of the new life science, named bioethics. This is in fact an effort to raise undervalued ethical principles again, reassess them in the Code of Medical Ethics, a status it deserves, and open space for bioethical thought. Bioethics emerges as a two-way science, because it involves doctors, researchers, patients and volunteers. The objectives of medical intervention should be explained, discussed and approved by interested parties. The hematologist has to put himself in the shoes of his patient, show him the clinical situation, pointing out the options for conduct and await the "placet". The proposal, therefore, aims to raise the professional to the safety of ethics and bioethical thought. The doctor takes an attitude better targeted at social achievement, offering him not only the appropriate treatment, but counting on his cooperation to achieve the desired results. This is a true symbiosis, which seeks to implement the principle of human dignity.
Bioethics; ethics; biolaw; biotechnoscience; biotechnology; adult stem cells (Hematopoietic)